The Lymphopenic Mouse in Immunology: From Patron to Pariah  by Singh, Nevil J. & Schwartz, Ronald H.
Immunity 25, 851–855, December 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.12.002CommentaryThe Lymphopenic Mouse
in Immunology:
From Patron to PariahNevil J. Singh1 and Ronald H. Schwartz1,*
1Laboratory of Cellular and Molecular Immunology
National Institute of Allergy and Infectious
Diseases (NIAID)
National Institutes of Health
4 / 111 Center Drive, MSC-0420
Bethesda, Maryland 20892
Summary
A recent surge of interest in the behavior of T and B
cells in lymphopenic model systems has resurrected
a certain cynicism about the validity of using such
models to answer important immunological ques-
tions. Here we discuss this skepticism in a broader
historical context.
The practice of studying the immune system by transfer-
ring immunological cells between two animals was
introduced in 1899 (Deutsch, 1899). Subsequently, Med-
awar and colleagues coined the term ‘‘adoptive immu-
nity’’ to symbolize the transfer of an immune response
from a donor to a fresh host by injection of the donor’s
serum or cells. But it was the refinement by Mitchison
of strategies to fractionate these cells and reintroduce
them in various ways and combinations that allowed
a burgeoning of immunological understanding in the
middle of the 20th century. His original experiments in
mice demonstrated that cells (and not antigen or anti-
bodies) from the lymph node draining a tumor were the
most effective mediators of adoptive immunity (Mitchi-
son, 1955). As it became clear that adoptive immunity
mirrored the donor’s own immune response, Mitchison
was intrigued by why the former response was short
lived relative to that of the latter. With characteristic
thoroughness, he then tested a variety of parameters
to improve the magnitude and duration of the trans-
ferred protection (Mitchison, 1957). The most successful
of his tweaks were the use of isogeneic hosts and the
surprising improvement attained by irradiating the host
before the adoptive transfer was performed (Mitchison,
1957). The enhancement of adoptive immunity as a result
of host irradiation was actually first demonstrated for
antibody production in rabbits (Harris et al., 1954). How-
ever, Mitchison standardized the protocol in mice and
demonstrated that the procedure greatly amplified the
readout of a variety of immunological responses, includ-
ing antiviral immunity.
The actual process by which irradiation of the host
augments immune responses has never been fully un-
derstood. The initial hypothesis was that the radiation
created ‘‘space’’ within the host, which improved en-
graftment of the lymphocytes. This is because hemato-
poietic cells are more susceptible to radiation-induced
cell death than most other cell types. A total body irradi-
ation (TBI) of 9Gy can deplete the mouse of lymphocytes
*Correspondence: rs34r@nih.govwithin 2 days, leading to lethality over the next 10 days
from bone marrow failure. The adoptive transfer experi-
ments usually employ a dose of 6Gy, which results in
complete depletion of mature B cells and 80% depletion
of mature T cells without killing the mouse. In recent
years, the availability of natural (SCID, nude) and in-
duced (Rag2/2, Cd332/2) genetic mutations has allowed
immunologists to more cleanly create such ‘‘space’’ for
adoptive transfer experiments without the need for TBI.
These newer models avoid the potential side effects of
radiation on other tissues and allow for the creation of
‘‘specific space’’ by leaving large parts of the hemato-
poietic system relatively intact. For example, in models
such as the scurfy mutant, the absence of a small (but
crucial) subset of lymphocytes creates a niche that
allowed investigators to adoptively transfer and study
the biology of natural T regulatory cells (nTregs) in vivo
(Fontenot et al., 2003). In the absence of a unifying
mechanistic definition of what ‘‘space’’ in the immune
system means, it is not clear that these different models
work under the same principles. Nonetheless, the list of
fundamental concepts in immunology that were initially
discovered via lymphopenic transfer models is quite
remarkable. These include the ideas of lymphocyte
antigen specificity, the role of the thymus, T cell help,
regulatory T cells, adaptive tolerance, and more.
The Lymphopenic Advantage
What is often forgotten, however, is that some of the
above-mentioned concepts may in fact have eluded dis-
covery were it not for the unique advantages accrued
from the use of lymphopenic hosts in adoptive transfer
models. In some cases this was merely because elimina-
tion of the host’s lymphocytes was essential to demon-
strate a property within the transferred population. This
is illustrated by experiments exploiting ‘‘hot-antigen sui-
cide,’’ where the specificity of naive B lymphocytes was
first demonstrated with irradiated hosts. In 1969, Ada
and Byrt transferred splenocytes that had been de-
pleted of flagellin-reactive cells by preincubating them
with I125-labeled flagellin. Subsequent challenge of the
recipients demonstrated the loss of anti-flagellin re-
sponses in the hot-antigen-treated groups, arguing for
the importance of specific antigen receptor-bearing
cells in the prechallenge repertoire for an antigen-spe-
cific response. In most other cases, however, the role
lymphopenia played was to augment the immunological
effect of the transferred cells. Many ‘‘classic’’ break-
throughs worked inefficiently in an intact animal—but
were convincingly demonstrated in lymphopenic hosts.
This is evident, for example, in the events leading up to
the original demonstration that T cell help is required for
antibody production. Claman and colleagues first ob-
served in irradiated mice that a thymus-derived cell must
interact with a bone marrow-derived cell in order to effi-
ciently generate an antibody response (Claman et al.,
1966).Keytosubsequentlyunderstandinghowthesetwo
cells interacted was the dissection of the carrier effect.
This phenomenon was first reported from the Benacerraf
laboratory, where humoral responses to small haptens
were greatly aided by linking them chemically to larger
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852(‘‘carrier’’) protein molecules. When animals were previ-
ously immunized with the carrier alone, a subsequent
challenge with a carrier-linked hapten resulted in en-
hanced hapten antibodies, but only if the same carrier
was used. These experiments led Rajewsky and Mitchi-
son to propose that the two cells in Claman’s experiment
must recognize different parts of the same antigen for
optimal antibody induction (Mitchison, 1971). However,
as Herzenberg points out, there were also reports of
a completely opposite carrier effect, i.e., immunizing in-
tact animals with a carrier led to suppression of subse-
quent anti-hapten responses, if the hapten was intro-
duced attached to the same carrier (Herzenberg et al.,
1983). The controversy of whether carrier immunization
enhances or suppresses the antibody response eventu-
ally tipped in favor of enhancement, largely because the
suppressive effect was not evident in adoptive transfer
experiments. In contrast, enhancement was robustly
demonstrated in such lymphopenic models (Mitchison,
1971; Herzenberg et al., 1983).
Although epitope-specific suppression initially lost
out in mainstream immunology because of the lympho-
penic host, its cousin the CD4+ nTreg got its blessing
from this type of experiment. The identification of
CD25 as a surface marker for CD4+ T cells with a sup-
pressive phenotype by Sakaguchi and coworkers
made studying them possible and led to the explosive
growth in this field. The path to CD25, however, can be
traced back to his earlier observation that repeated
low-dose whole-body irradiation led to the development
of autoantibodies in BALB/c mice (Sakaguchi et al.,
1994). Not only did this disease require the residual
CD4+ T cells that survived the radiation, but it could
also be prevented by adoptively transferring CD4+
T cells from nonirradiated animals. His efforts to further
fractionate the suppressor subset within the latter
cohort led to the isolation of the CD25+CD4+ regulatory
T cells (Sakaguchi et al., 1995). In these experiments,
they transferred the CD25+ cells alone or in combination
with effector T cells into nude mice—a T cell-selective,
genetically lymphopenic animal—to demonstrate sup-
pression. The importance of the choice of such a model
on the course of the last 10 years of cellular immunology
cannot be overstated. Years later, when McHugh and
Shevach attempted to eliminate the CD25+ T cell in
a nonlymphopenic setting, it had little effect on the
health of the mouse (McHugh and Shevach, 2002). But
of course by then, many other experiments including
those by the Shevach laboratory had already estab-
lished the importance of the CD25+ T cell in immunolog-
ical dogma.
A Fear of Empty Spaces
It is rather ironic, then, that the first inroads into dissect-
ing the process of lymphopenia have evoked a negative
reaction toward the validity of experimental observa-
tions made with lymphopenic models in general. The
impetus for such a reaction is the perception that the
behavior of lymphocytes in lymphopenic environments
contravenes immunological dogma: namely, that mature
T cells must first be stimulated by a cognate antigen
before they can proliferate and differentiate. By contrast,
experiments transferring limited numbers of peripheral
T cells to athymic nude rats revealed a ‘‘homeostatic’’
process in which the T cells expanded in the absenceof immunization, enough to reconstitute a variety of im-
munological functions (Bell et al., 1987). Subsequently, it
was shown that a lymphopenic setting prompted even
T cell receptor (TCR) transgenic T cells of a naive pheno-
type to proliferate ‘‘spontaneously’’ in the absence of
cognate antigen (Bruno et al., 1996; Ernst et al., 1999).
This proliferation was not always a neutral event be-
cause the dividing cells acquired many markers asso-
ciated with antigen-dependent T cell differentiation—
including surface phenotype and effector functions
(Cho et al., 2000). Even an extensive gene-expression
analysis of cells that had expanded and differentiated
in the apparent absence of cognate antigen concluded
that they resembled the ‘‘conventional’’ effector or
memory T cells (Goldrath et al., 2004). In addition, the
differentiation process was largely irreversible, leading
many to question the idea that this was truly ‘‘homeo-
static’’—because apart from the cell numbers, very little
was preserved as a result of the proliferative expansion.
This unexpected behavior of cells hitherto thought to
remain quiescent until actively stimulated by cognate
antigen engendered the reaction that a lymphopenic en-
vironment represented an experimental oddity that pro-
voked an artifactual behavior from T cells. However, this
notion is not strictly correct, because a similar T cell be-
havior is observed in a naturally lymphopenic setting
that occurs during the first week of life of a neonatal
mouse (Le Campion et al., 2002; Min et al., 2003). Fur-
thermore, antigen-independent ‘‘spontaneous’’ prolifer-
ation of naive T cells has recently been observed in in-
tact animals when extremely sensitive techniques were
used to detect such proliferation in low-frequency pop-
ulations (Hataye et al., 2006). Thus, once again, it seems
likely that lymphopenia is merely serving to amplify the
measurement of a physiological property of a subset
of mature peripheral T cells.
Cytokines and TCR Ligands in Lymphopenic
Proliferation
Apart from antigen engagement, the clonal response of
T cells requires a series of cytokine signals that encour-
age proliferation, differentiation, and survival of the
stimulated T cells. Experiments on the slow turnover of
memory CD8+ T cells in the absence of an ongoing im-
mune response suggested that this form of proliferation
could be largely regulated by the cytokine IL-15 (Judge
et al., 2002). These findings led Sprent, Surh, Swain,
and others to identify the role of cytokines such as IL-7
and IL-15 in the induction of lymphopenic proliferation
(Surh and Sprent, 2005). The absence of a large number
of lymphocytes to compete for these cytokines may
allow the cells resident in a lymphopenic host to accu-
mulate sufficient signals to trigger a proliferative expan-
sion. It was also evident in their early studies that block-
ing MHC-TCR interactions prevented this proliferation,
even if the cytokines were present (Ernst et al., 1999).
Because the T cells proliferating in lymphopenic hosts
can do so in the absence of their cognate antigens, the
source of peptides that may be presented on the MHC
remains controversial. T cells in the thymus undergo
positive selection on epitopes derived from endogenous
proteins, and the continued presence of those pMHC
complexes in the periphery may serve as a ligand for
at least some TCRs (Ernst et al., 1999; Goldrath and
Bevan, 1999). Alternatively, antigens acquired from
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ate epitopes that are recognized weakly by certain TCRs
(Kieper et al., 2005). In either case, the behavior of these
T cells resembles the proliferation of T cells in a synge-
neic mixed leukocyte response (MLR), the triggers for
which also remain to be resolved.
The involvement of TCR-mediated pMHC recognition
in the initiation of T cell proliferation in a lymphopenic
host has itself been a fairly controversial area. This
stems from studies that demonstrate that lymphopenic
proliferation can proceed even in the absence of cog-
nate MHC molecules (Clarke and Rudensky, 2000;
Grandjean et al., 2003). But even here, the total removal
of MHC can have other consequences such as on the
differentiation of the proliferating cells (Grandjean
et al., 2003). Moreover, further studies are required to
clarify whether an extremely weak level of crossreactiv-
ity with unrelated MHC molecules—including with non-
restricting alleles (i.e., MHC I or even nonclassical
MHC for CD4s)—may in fact be sufficient to trigger this
form of proliferation, at least in some T cells. In other
experiments, where the blockade of MHC-TCR inter-
actions was achieved by means of antibody treatment
(instead of MHC-deficient mice), the lymphopenic prolif-
eration seemed to absolutely require MHC interaction
(Dorfman et al., 2000). Some of the variability in these
and other studies may originate from the properties of
individual model systems or may truly reflect the hetero-
geneity of proliferative cues that exist in vivo. Similar
issues (regarding the role of cytokines and the role of
antigen during the proliferative expansion of T cells)
remain under active investigation even in the case of
‘‘true’’ antigen-driven T cell expansion and differen-
tiation (Jelley-Gibbs et al., 2000). The question still re-
mains, however, as to how each of these cues is able
to stimulate a much more robust response in a lympho-
penic setting than in an intact host.
A potential resolution of this problem may lie in the
phenomenon of resource competition between lympho-
cytes (Freitas and Rocha, 2000). For example, it has
recently become evident that early in their activation
phase, T cells sharing the same specificity actively
compete for limiting amounts of cognate peptide-MHC
complexes (Sojka et al., 2004). The net effect of such
a competition is to limit the amount of antigenic signal
available for each T cell and can be compensated for
by simply increasing the dose of total antigen. This phe-
nomenon may very well apply to the perception of the
weak ligand in the lymphopenic (noncompetitive) versus
intact (competitive) environments. Therefore, a ‘‘weak’’
signal that only elicits a barely measurable response in
an intact animal (like the proliferation measured by
Hataye et al. [2006] or the TCR zeta phosphorylation
reported by Dorfman et al. [2000]) may be sufficient to
trigger a more robust and easily measurable response
in a lymphopenic animal. Of course, the stronger stimu-
lus would also elicit greater differentiation and effector
functions in a manner similar to antigen dose responses
in an intact animal. A similar model can also be con-
structed for cytokine signals, and it may very well be the
synergy between these two relatively weak signals that
made possible much of the historical merits of the lym-
phopenic models (Patke et al., 2004; Surh and Sprent,
2005). Although such ideas are attractive in that theyunify the concepts surrounding lymphocyte responses
induced by cognate antigen and lymphopenia, these
models still need to be experimentally validated. And it
would ultimately be such experiments that will help dis-
pel the notoriety that lymphopenic models have recently
acquired.
Working with Lymphopenic Models
Despite the obvious value that lymphopenic mouse
models have had for cellular immunology in the past,
they should not be used without paying close attention
to their potential pitfalls. The paucity of studies that ac-
tually measure in parallel a variety of immunological
functions in lymphopenic and intact animals makes it
difficult to arrive at a comprehensive list of such draw-
backs. Nevertheless, the propensity of T cells to divide
spontaneously in lymphopenic hosts needs to be con-
trolled for, especially in long-term experiments that
also measure the proliferation and differentiation of T
cells to another stimulus. The lymphopenic response
seems to vary with the TCR, possibly being related to
its affinity for the stimulating ligand (Surh and Sprent,
2005). In a model we use, the lymphopenia-driven prolif-
eration of antigen-specific T cells is not initiated for 6–8
days, whereas the cognate antigen triggers robust pro-
liferation within 2 days (Tanchot et al., 2001). The subse-
quent doubling of the T cells in the lymphopenic setting
continues to be extremely slow (1–2 weeks) relative
to the rapid doubling in response to antigen (4–5 hr).
The responses to cognate antigen, however, are clearly
influenced by lymphopenia, where the absolute expan-
sion of cells is 10-fold greater than that seen in an intact
animal, because the proliferation continues for an extra
day (Singh et al., 2006). Consistent with the idea that
lymphopenia amplifies the effective strength of the
available stimulus, T cells in such environments also
differentiate more robustly (Figure 1). Clearly, this ampli-
fication process can have profound consequences on
the development of pathology or the efficacy of clinical
protocols that aim to modulate T cell responses in
such situations (Wu et al., 2004; Singh et al., 2006). But
the lymphopenic model per se still retains significant
power in such a comparative setting. In our case, it
was useful to dissociate the components of immunoreg-
ulation that were strictly T cell intrinsic from aspects that
required trans interactions from other T cells. Surpris-
ingly, the latter also included the clonal elimination of
self-reactive T cells in the periphery, which has widely
been assumed to always be a cell-intrinsic program sim-
ilar to clonal deletion in the thymus (Singh et al., 2006).
In a similar vein, recent studies have highlighted the
problem of translating tolerance induction protocols
from intact animals to lymphopenic model systems
(Wu et al., 2004). Part of the difficulty is associated
with the expansion of memory T cells, which either pro-
liferate or survive better in the lymphopenic space. This
is, however, quite relevant to clinical scenarios such as
those following bone marrow transplantation, tumor
immunotherapy, or even some viral infections, where
lymphocyte depletion occurs frequently. Once such var-
iables are clearly defined, then the lymphopenic animal,
with its excess of memory cells, may even become the
better model in which to develop tolerance induction
regimens. In fact, this approach may also be more appli-
cable than currently thought because a clinical tolerance
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854Figure 1. Naive T Cell Responses to Antigen in a Lymphopenic versus Intact Environment
The lymphopenic environment (top) amplifies many aspects of the behavior of adoptively transferred naive T cells that may even be difficult to
assay in an intact animal (bottom). Some of these relate to the reduced competition with host lymphocytes for antigen-presenting cells, peptide-
MHC complexes, or cytokines. As a result, the clonal expansion, effector differentiation, and survival of the responding cells may be proportion-
ally greater. Although many truly cell-autonomous events such as adaptive tolerance are preserved in both environments, some tolerance induc-
tion protocols may not work efficiently. Occasionally, the amplified effector functions such as help for B cells or direct cytotoxicity can lead to the
development of greater immunopathology (Singh et al., 2006). Such immunopathology may be further exacerbated in lymphopenic models that
also lack regulatory lymphocytes such as NK T cells, gd T cells, or nTregs that may modulate the effector response or participate in the repair of
tissue damage.protocol needs to be effectual on a large number of
heterologous memory and effector T cells, even in non-
lymphopenic patients.
Finally, studies that critically rely on the intact archi-
tecture of the secondary lymphoid organs or any tissue
that markedly interfaces with the immune system (e.g.,
gut or lung) may be impacted by the use of lymphopenic
hosts. Cellular products from lymphocytes have been
shown to contribute to the development and homeosta-
sis of many such tissues. Even lymphocyte trafficking
can be affected in some models (e.g., Rag2/2) because
of the need for prior interaction with high endothelial
venules to facilitate optimal lymphocyte diapedesis.
Some of these deficiencies may be corrected by choos-
ing an appropriate model of lymphopenia (for example,
TCRa-deficient mice instead of Rag-deficient). Alterna-
tively, the mechanistic details of a phenomenon, after
being worked out in a lymphopenic model, may simply
be ‘‘validated’’ in other settings—whether in an intact
animal or by clinical observations. In the current climate
of ‘‘in vivo veritas,’’ the use of lymphopenic models
may still be preferred to certain in vitro models for a re-
ductionistic analysis. Finally, given that the organization
of the secondary lymphoid organs differs between spe-
cies, it may not be so easy to determine whether the
lymphopenic or ‘‘intact’’ mouse is the best model withregards to the potential for translating immunological
observations to humans.
Epilogue
The argument over what constitutes a ‘‘physiological’’
model or technique for the study of any particular exper-
imental question is a frequent one in most biology labo-
ratories. Although any particular approach may wax and
wane in popularity at any given period, the fact remains
that all models are simply that: model systems. Each ex-
perimental observation, then, is best understood within
the constraints of the particular model and the conclu-
sions translated to other scenarios only after due con-
sideration of the limits of the original model as well as
the novelties arising in translation. Such a rationale has
been widely and effectively used in the development of
disease models that often exploit infections or malig-
nancies that do not naturally develop in the animal under
study. It would seem quite unfair, then, to instinctively
reject any observation simply because it originated in
a particular experimental construct—in this case the
lymphopenic mouse. In fact, the skepticism over the us-
age of such hosts to study immunological interactions is
not that new at all. Summarizing his opinion in 1974 of
the vast (and confusing) outpouring of data regarding
lymphocyte interactions, Sir MacFarlane Burnet con-
fessed to a ‘‘certain skepticism about the significance
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pure line mice, neonatally thymectomised, lethally irra-
diated, and salvaged by injection of bone marrow from
another mouse.’’ With the wisdom of hindsight, it is in-
teresting to note that the claims that induced Burnet to
make these comments (T cell help for B cells and the im-
munological role of the thymus) have since been vali-
dated extensively. The value of healthy skepticism in
the analysis of any experiment is obvious, but the blan-
ket disregard for all data merely driven by a prejudicial
rejection of an experimental model is likely to be coun-
terproductive. The mechanistic details of the behavior
of the adoptive immune system in a lymphopenic
animal, which presents a ‘‘magnifying glass’’ to many
immunological phenotypes, remains to be fully under-
stood. Given the breadth of this effect, however, such
an understanding promises to be quite rewarding.
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